Astellas Pharma Inc
XMUN:YPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Astellas Pharma Inc
XMUN:YPH
|
JP |
|
SPB Birzha PAO
MOEX:SPBE
|
RU |
|
M
|
Muang Thai Insurance PCL
SET:MTI
|
TH |
|
T
|
Toyota Motor Corp
DUS:TOM
|
JP |
|
Star Entertainment Group Ltd
ASX:SGR
|
AU |
Wall St Price Targets
YPH Price Targets Summary
Astellas Pharma Inc
According to Wall Street analysts, the average 1-year price target for YPH is 12.89 EUR with a low forecast of 9.17 EUR and a high forecast of 17.38 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is YPH's stock price target?
Price Target
12.89
EUR
According to Wall Street analysts, the average 1-year price target for YPH is 12.89 EUR with a low forecast of 9.17 EUR and a high forecast of 17.38 EUR.
What is the Revenue forecast for Astellas Pharma Inc?
Projected CAGR
-4%
Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is -4%.
What is the Gross Profit forecast for Astellas Pharma Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is -2%.
What is the Pre-Tax Income forecast for Astellas Pharma Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 2 years is 9%.
What is the Net Income forecast for Astellas Pharma Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 2 years is 5%.
